作者: Scott A. Fink , Ira M. Jacobson
关键词: Cirrhosis 、 Internal medicine 、 Adverse effect 、 Liver transplantation 、 Medicine 、 Hepatitis C 、 Hepatitis B 、 Gastroenterology 、 Exacerbation 、 Decompensation 、 Hepatocellular carcinoma
摘要: Treatment of patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis should focus on controlling the complications cirrhosis, surveillance for hepatocellular carcinoma and, if applicable, preparation orthotopic liver transplant. Interferon-based regimens treatment hepatitis C have been somewhat successful in although be approached caution. Given potential exacerbation decompensation and poor tolerance adverse effects, reserved those awaiting transplantation. Eradication HCV before transplantation reduces chances recurrent infection after HBV can treated few effects cirrhosis. This is associated improvement some patients. Hepatocellular remains a significant risk all control eradication does not remove this risk.